Effect of Kinesiotape on Emesis in Pregnant Women

Launched by CAIRO UNIVERSITY · Oct 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of kinesiotape, a special type of tape often used in sports, to see if it helps reduce nausea and vomiting in pregnant women. The trial will involve about 50 women who are between 6 to 12 weeks pregnant and experiencing mild to moderate nausea and vomiting, a condition known as emesis. To join the study, participants need to be first-time mothers, aged 20 to 35, and have a body mass index (BMI) of less than 30.

If you are eligible and choose to participate, you will be part of a research effort that aims to improve comfort for pregnant women dealing with nausea. Participants will be monitored throughout the study to understand how effective kinesiotaping is for this issue. It's important to note that women with certain health conditions, multiple pregnancies, or severe nausea will not be included in this trial. The study is not yet recruiting, so if you’re interested, keep an eye out for updates!

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Fifty pregnant women at 6th to 12th weeks of gestation diagnosed with mild to moderate nausea and vomiting.
• • The diagnosis of EG is confirmed by Rhodes index.
• • Their ages will be ranged from 20 to 35years old.
• • Their body mass index will be less than 30 kg/m2.
• • All of them are primigravida.
• Exclusion Criteria:
• • Digestive system diseases, inflammatory bowel disease, gastric ulcers and/or esophagitis.
• • Twins or more.
• • Obese women with BMI \<30 kg/m2.
• • Severe emesis or hyperemesis gravidarum.
• • Risk of threatened or habitual abortion.
• • Multi gravida.
• • Thyroid or liver dysfunction.